Shenzhen Weiguang Biological Products Co., Ltd. (SHE:002880)

SHE:002880 Revenue

Shenzhen Weiguang Biological Products had revenue of 207.79M CNY in the quarter ending September 30, 2026, a decrease of -23.83%. This brings the company's total for the last twelve months to 1.13B, down -0.65% year-over-year. In the year 2025, Shenzhen Weiguang Biological Products had annual revenue of 1.27B with 5.28% growth. That makes Shenzhen Weiguang Biological Products the 18,700th largest company in the world by revenue and 3,422nd in China.

• Revenue (ttm): 1.13B
• Revenue Growth: -0.65%
• P/S Ratio: 4.09
• Revenue / Employee: 1.26M
• Employees: 901
• Market Cap: 4.57B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Blood Products 1.11B 87.5%
• Property Lease 141.56M 11.2%
• Unallocated Other Industry 16.66M 1.3%

Fiscal year ended Dec 31, 2025 See the full SHE:002880 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.27B	63.47M	5.28%
Dec 31, 2024	1.20B	154.69M	14.75%
Dec 31, 2023	1.05B	380.57M	56.98%
Jan 1, 2023	667.93M	-239.50M	-26.39%
Jan 1, 2022	907.43M	2.87M	0.32%

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 3, 2026

Data Sources Report a data error